SEBPharm Limited |
Notes to the Accounts |
for the period from 1 June 2023 to 29 February 2024 |
|
|
1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Intangible fixed assets |
|
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Leasehold land and buildings |
over the lease term |
|
Plant and machinery |
25% reducing balance |
|
Fixtures, fittings, tools and equipment |
25% reducing balance |
|
|
Stocks |
|
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Pensions |
|
Contributions to defined contribution plans are expensed in the period to which they relate. |
|
|
2 |
Employees |
2024 |
|
2023 |
Number |
Number |
|
|
Average number of persons employed by the company |
11 |
|
10 |
|
|
|
|
|
|
|
|
|
|
3 |
Intangible fixed assets |
£ |
|
Goodwill: |
|
|
Cost |
|
At 1 June 2023 |
1,085,576 |
|
At 29 February 2024 |
1,085,576 |
|
|
|
|
|
|
|
|
|
|
Amortisation |
|
At 1 June 2023 |
1,085,576 |
|
At 29 February 2024 |
1,085,576 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 29 February 2024 |
- |
|
|
|
|
|
|
|
|
|
|
Goodwill is being written off in equal annual instalments over its estimated economic life of 10 years. |
|
|
4 |
Tangible fixed assets |
|
|
Land and buildings |
|
Plant and machinery etc |
|
Motor vehicles |
|
Total |
£ |
£ |
£ |
£ |
|
Cost |
|
At 1 June 2023 |
9,891 |
|
50,571 |
|
98,362 |
|
158,824 |
|
Additions |
- |
|
275 |
|
- |
|
275 |
|
Disposals |
- |
|
- |
|
(89,264) |
|
(89,264) |
|
At 29 February 2024 |
9,891 |
|
50,846 |
|
9,098 |
|
69,835 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 June 2023 |
1,385 |
|
48,386 |
|
59,858 |
|
109,629 |
|
Charge for the period |
148 |
|
461 |
|
4,331 |
|
4,940 |
|
On disposals |
- |
|
- |
|
(58,209) |
|
(58,209) |
|
At 29 February 2024 |
1,533 |
|
48,847 |
|
5,980 |
|
56,360 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 29 February 2024 |
8,358 |
|
1,999 |
|
3,118 |
|
13,475 |
|
At 31 May 2023 |
8,506 |
|
2,185 |
|
38,504 |
|
49,195 |
|
|
5 |
Debtors |
2024 |
|
2023 |
£ |
£ |
|
|
Trade debtors |
146,462 |
|
102,736 |
|
Other debtors |
394,845 |
|
339,782 |
|
|
|
|
|
|
541,307 |
|
442,518 |
|
|
|
|
|
|
|
|
|
|
6 |
Creditors: amounts falling due within one year |
2024 |
|
2023 |
£ |
£ |
|
|
Trade creditors |
178,658 |
|
180,625 |
|
Taxation and social security costs |
12,090 |
|
12,722 |
|
Other creditors |
5,265 |
|
4,314 |
|
|
|
|
|
|
196,013 |
|
197,661 |
|
|
|
|
|
|
|
|
|
|
7 |
Events after the reporting date |
|
|
The company's entire ordinary share capital was acquired by Raif Pharma Limited on the 7th March 2024. |
|
|
8 |
Related party transactions |
|
|
The company leases its trading premises from SE Bargh. |
|
|
9 |
Controlling party |
|
|
In the opinion of the directors, the controlling party is Raif Pharma Limited. |
|
|
10 |
Other information |
|
|
SEBPharm Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
2 Carlton Lane |
|
Lofthouse |
|
Wakefield |
|
WF3 3LJ |